Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM639251 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | IRAK4 ADP-Glo Assay | ||
IC50 | 3.00±n/a nM | ||
Citation | Chen, Y; Masuda, E; Lamagna, C BICYCLIC INHIBITORS OF IRAK US Patent US20230391748 Publication Date 12/7/2023 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM639251 | |||
n/a | |||
Name | BDBM639251 | ||
Synonyms: | 1-(((S)-4,4-difluoro-5-oxopyrrolidin-2-yl)methoxy)-4-(1-(cis-3-(dimethylamino)cyclobutyl)-1H-pyrazol-4-yl)-7-isopropoxyisoquinoline-6-carboxamide | US20230391748, Compound I-73 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H32F2N6O4 | ||
Mol. Mass. | 542.5776 | ||
SMILES | CC(C)Oc1cc2c(OC[C@@H]3CC(F)(F)C(=O)N3)ncc(-c3cnn(c3)[C@@H]3C[C@@H](C3)N(C)C)c2cc1C(N)=O |r,wU:10.9,26.27,28.32,(4.85,5.94,;4.08,4.6,;4.85,3.27,;2.54,4.6,;1.77,3.27,;2.54,1.94,;1.77,.6,;2.54,-.73,;4.08,-.73,;4.85,-2.07,;6.39,-2.07,;7.29,-3.31,;8.76,-2.84,;10.25,-3.23,;9.53,-4.17,;8.76,-1.3,;10.09,-.53,;7.29,-.82,;1.77,-2.07,;.23,-2.07,;-.54,-.73,;-2.08,-.73,;-2.99,.51,;-4.45,.04,;-4.45,-1.5,;-2.99,-1.98,;-5.78,-2.27,;-7.27,-1.87,;-7.67,-3.36,;-6.18,-3.76,;-8.76,-4.45,;-10.25,-4.05,;-8.36,-5.94,;.23,.6,;-.54,1.94,;.23,3.27,;-.54,4.6,;.23,5.94,;-2.08,4.6,)| | ||
Structure |